Source: Health Products Regulatory Authority (ZA) Revision Year: 2022 Publisher: Adcock Ingram Limited, 1 New Road, Erand Gardens, Midrand, 1685, South Africa 0860 ADCOCK (232625)
BLADURIL 200 mg, film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablets. White, homogeneous film-coated tablets with “F200” embossed. |
Each film-coated tablet contains 200 mg flavoxate hydrochloride.
Excipient with known effect:
Contains sugar (lactose monohydrate): 64 mg.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Flavoxate |
Flavoxate is an antispasmodic selective to the urinary tract. Flavoxate has been shown to have a direct antispasmodic action on smooth muscle fibres. |
| List of Excipients |
|---|
|
Core: Lactose monohydrate Coating: Macrogol 6000 |
Cartons of 15 tablets: Each carton contains 1 blister strip containing 15 tablets.
Cartons of 90 tablets: Each carton contains 6 blister strips containing 15 tablets per blister strip.
Not all pack sizes may be marketed.
Adcock Ingram Limited, 1 New Road, Erand Gardens, Midrand, 1685, South Africa
0860 ADCOCK (232625)
56 0136
10 May 2022
| Drug | Countries | |
|---|---|---|
| BLADURIL | Ecuador, Mexico, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
